MWM
NWBO

Maripau Wealth Management’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Maripau Wealth Management’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-39,493
Closed -$16.9K – 149
2024
Q2 		$16.9K Hold
39,493
– – 0.01% 142
2024
Q1 		$20.5K Buy
+39,493
New +$20.5K 0.02% 137

Other funds holding NWBO

MSAM
Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return
KA
KLCM Advisors Milwaukee, Wisconsin $1.19B AUM 34.45% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $549M AUM 29.35% 1-Year Est. Return

Maripau Wealth Management's NWBO Position: Q3 2024 in Review

Maripau Wealth Management sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q3 2024, closing a stake of 39,493 shares — an estimated $16.9K sold.

Maripau Wealth Management first reported a position in NWBO in Q1 2024 and held it in 2 quarters. The position peaked at $20.5K in Q1 2024. 11 funds tracked by Wall St. Rank hold NWBO as of Q3 2024.

  • Maripau Wealth Management reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q3 2024 after selling out during the quarter.
  • Maripau Wealth Management sold 39,493 Northwest Biotherapeutics, Inc. Common stock shares in Q3 2024, an estimated $16.9K.
  • Maripau Wealth Management first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q1 2024 and held it in 2 quarters.
  • Maripau Wealth Management's Northwest Biotherapeutics, Inc. Common stock position peaked at $20.5K in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q3 2024.

Based on Maripau Wealth Management's 13F filing for Q3 2024, filed 21 Oct 2024.